Henry Ford Medical Group is a clinical research site located in Detroit, Michigan, United States 48202.
Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.
Henry Ford Medical Group has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome.
Sponsors: Genmab, NuCana plc.
Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Henry Ford Medical Group has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Henry Ford Medical Group has 2 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome.
Henry Ford Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.